Comprehensive analysis of genetic associations and single-cell expression profiles reveals potential links between migraine and multiple diseases: a phenome-wide association study

Front Neurol. 2024 Feb 7:15:1301208. doi: 10.3389/fneur.2024.1301208. eCollection 2024.

Abstract

Migraine is a common neurological disorder that affects more than one billion people worldwide. Recent genome-wide association studies have identified 123 genetic loci associated with migraine risk. However, the biological mechanisms underlying migraine and its relationships with other complex diseases remain unclear. We performed a phenome-wide association study (PheWAS) using UK Biobank data to investigate associations between migraine and 416 phenotypes. Mendelian randomization was employed using the IVW method. For loci associated with multiple diseases, pleiotropy was tested using MR-Egger. Single-cell RNA sequencing data was analyzed to profile the expression of 73 migraine susceptibility genes across brain cell types. qPCR was used to validate the expression of selected genes in microglia. PheWAS identified 15 disorders significantly associated with migraine, with one association detecting potential pleiotropy. Single-cell analysis revealed elevated expression of seven susceptibility genes (including ZEB2, RUNX1, SLC24A3, ANKDD1B, etc.) in brain glial cells. And qPCR confirmed the upregulation of these genes in LPS-treated microglia. This multimodal analysis provides novel insights into the link between migraine and other diseases. The single-cell profiling suggests the involvement of specific brain cells and molecular pathways. Validation of gene expression in microglia supports their potential role in migraine pathology. Overall, this study uncovers pleiotropic relationships and the biological underpinnings of migraine susceptibility.

Keywords: genetic association study; microglia; migraine; phenome-wide association study; single-cell RNA sequencing; susceptibility gen.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the 2023 Special Fund Project for Inheritance and Development of Traditional Chinese Medicine in Guangxi Zhuang Autonomous Region [Guangxi Traditional Chinese Medicine Development (2023) No. 1], 2023 Fund Project for the Improvement of Guangxi Medical Service and Security Ability [Guizhong Medical Development (2023) No. 2], and the Guangxi Key Research Laboratory of Traditional Chinese Medicine Construction Project [Guangxi Traditional Chinese Medicine Science and Education Development (2023) No. 9].